By focusing on innovative, long-lasting pain relief methods, Brixton is well-positioned to contribute to the shift away from opioid dependence. The company’s technologies align with the objectives of ...

The European Commission has approved Pfizer’s treatment for adults and adolescents with severe hemophilia A or B.

From discovering her knack for chemistry in high school to proving her expertise in male-dominated spaces, Tran Pham has ...

The global contract development and manufacturing organization ​ (CDMO), Samsung Biologics, announced this week that it has ...

From developing treatments for Ebola to mastering karate with her daughters, Dr. Helen Harrington’s journey is one of ...

The promising trial results put icotrokinra on track to fulfill its potential as a best in class oral therapeutic for the chronic skin condition. The phase 3 ICONIC-LEAD study showed that icotrokinra, ...

Muvalaplin significantly lowered lipoprotein(a) levels, reducing the risk of cardiovascular events in high-risk adults. Yesterday, Eli Lilly and Company revealed promising Phase 2 results for its ...

The financing round will fund the improvement of the company’s technology platform for the discovery and development of innovative radionuclide drug conjugates. C Ray Therapeutics has announced the ...

The financing round will fund the improvement of the company’s technology platform for the discovery and development of innovative radionuclide drug conjugates.

We offer cutting-edge synthesis services trusted by leading research labs and companies worldwide. Innovative, robust and scalable chemistry is the core strength of Laurus. We support drug development ...

We stock 1000's of pieces of equipment covering 275 distinct categories. Used equipment from Federal Equipment Company offers several opportunities for cost savings including purchase price savings, ...